$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
达罗他胺可用于治疗转移性激素敏感性前列腺癌(mHSPC)患者
2025-10-19 11:44:20
Check Details
阿比特龙治疗前列腺癌疗效如何?总生存期高达34.7!如何服用?
2025-10-19 11:44:20
Check Details
再获突破,Xtandi在Ⅲ期EMBARK试验达成主要终点
2025-10-19 11:44:20
Check Details
拜耳「达罗他胺片」新适应症在中国获批
2025-10-19 11:44:20
Check Details
2023CSCO肿瘤心脏病学更新亮点-前列腺癌GnRH拮抗剂替代GnRH激动剂
2025-10-19 11:44:20
Check Details
2023年恩杂鲁胺报销条件是什么?
2025-10-19 11:44:20
Check Details
阿比特龙副作用有哪些
2025-10-19 11:44:20
Check Details
阿比特龙的功效和作用
2025-10-19 11:44:20
Check Details
恩扎卢胺的治疗效果如何?
2025-10-19 11:44:20
Check Details
阿比特龙治什么病效果最好?
2025-10-19 11:44:20
Check Details
服用比卡鲁胺片的禁忌
2025-10-19 11:44:20
Check Details
阿帕他胺的不良反应
2025-10-19 11:44:20
Check Details
1
2
...
1579
1580
1581
1582
1583
1584
1585
...
4158
4159
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
2
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
3
Lapatinib: Proper Administration Guide and Key Precautions
4
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
5
Cemiplimab Storage and Handling Guide
6
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
7
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring
8
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements
9
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
10
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
11
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma
12
Selpercatinib Dosing Guide: Weight-Based Precision Targeting for RET-Driven Tumors